Nachrichten zur Hims & Hers Health Aktie

Insider Sale: CFO Oluyemi Okupe Sells Shares of Hims & Hers Health Inc (HIMS)

Oluyemi Okupe, Chief Financial Officer of Hims & Hers Health Inc (HIMS), sold 9,868 shares of the company on October…

Hims & Hers Health, Inc. (NYSE:HIMS) Shares Bought by Strategic Wealth Partners Ltd.

Strategic Wealth Partners Ltd. grew its position in shares of Hims & Hers Health, Inc. (NYSE:HIMS - Free Report)…

Hims and Hers stock swings on index inclusion, FDA lawsuit concerns

Hims and Hers stock swings on index inclusion, FDA lawsuit concerns - Truist…

Hims and Hers stock swings on index inclusion, FDA lawsuit concerns

Hims and Hers stock swings on index inclusion, FDA lawsuit concerns - Truist…

Healthy Returns: What activist Starboards $1 billion stake means for Pfizer

Pfizers troubles may finally be coming to a head. Meanwhile, Hims & Hers is joining S&P SmallCap 600.…

Hims & Hers Health, Inc. (NYSE:HIMS) COO Sells $1,149,737.50 in Stock

Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) COO Melissa Baird sold 58,750 shares of the business’s stock…

Oluyemi Okupe Sells 9,868 Shares of Hims & Hers Health, Inc. (NYSE:HIMS) Stock

Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) CFO Oluyemi Okupe sold 9,868 shares of the business’s stock…

Hims & Hers health CFO sells shares worth nearly $197k By Investing.com

Hims & Hers health CFO sells shares worth nearly $197k…

Hims & Hers health CFO sells shares worth nearly $197k By Investing.com

Hims & Hers health CFO sells shares worth nearly $197k…

Hims & Hers Stock Joins S&P 600: Is More Upside on the Horizon?

There is now a new reason to look into Hims & Hers stock for additional upside, including the new addition…

Hims & Hers Health (HIMS) Soars 10.1%: Is Further Upside Left in the Stock?

Hims & Hers Health (HIMS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings…

Hims & Hers Health (HIMS) Soars 10.1%: Is Further Upside Left in the Stock?

Hims & Hers Health, Inc. HIMS shares rallied 10.1% in the last trading session to close at $19.44. This move…

HIMS Stock Rises 208% in a Year and Is Ready to Compete with the Big Guns

As a player in the growing telehealth sector, Hims Hers Health ($HIMS) has grown significantly, driving its stock up…

Hims & Hers Health Target of Unusually High Options Trading (NYSE:HIMS)

Hims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) was the target of some unusual options trading activity on…

Hims & Hers Health (NYSE:HIMS) Shares Gap Up

Hims & Hers Health (NYSE:HIMS) Shares Gap Up - Still a Buy?…

Is Trending Stock Hims & Hers Health, Inc. (HIMS) a Buy Now?

Hims & Hers Health (HIMS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise…

Die Aufnahme von Hims & Hers in den S&P SmallCap 600 könnte den Short Squeeze einleiten

Hims & Hers wird am 9. Oktober 2024 in den S&P SmallCap 600-Index aufgenommen, was für das Unternehmen ein wichtiger…

HIms & Hers shares rise premarket on upcoming inclusion in S&P SmallCap 600 By Investing.com

HIms & Hers shares rise premarket on upcoming inclusion in S&P SmallCap 600…

Healthcare of Ontario Pension Plan Trust Fund Purchases 328,142 Shares of Hims & Hers Health, Inc. (NYSE:HIMS)

Healthcare of Ontario Pension Plan Trust Fund lifted its position in shares of Hims & Hers Health, Inc. (NYSE:HIMS…

Hims & Hers stock to join the S&P SmallCap 600 (NYSE:HIMS)

Hims & Hers Health (HIMS) is expected to join the S&P SmallCap 600 Index on Wedensday, replacing Vector Group (VIGR),…

Hims & Hers to replace Vector Group in the S&P SmallCap 600

…

Hims & Hers to replace Vector Group in the S&P 600 as of 10/9

Hims Hers Health (HIMS) will replace Vector Group Ltd (VGR) in the SP SmallCap 600 effective prior to the…

Hims & Hers falls after FDA says Lilly weight loss drug shortage is over

The Food and Drug Administration last night said it determined the shortage of tirzepatide injection, a glucagon-like peptide medication, has…

Tirzepatide news constrains Hims & Hers addressable market, says Citi

Citi keeps a Neutral rating on Hims Hers (HIMS) after the FDA officially removed Eli Lilly’s (LLY) Tirzepatide from…

Hims & Hers Health Set to Join S&P SmallCap 600

NEW YORK, Oct. 4, 2024 /PRNewswire/ -- Hims & Hers Health, Inc. (NYSE:HIMS) will replace Vector Group Ltd (NYSE:VGR) in…

Hims & Hers Health Set to Join S&P SmallCap 600

NEW YORK, Oct. 4, 2024 /PRNewswire/ -- Hims & Hers Health, Inc. (NYSE:HIMS) will replace Vector Group Ltd (NYSE:VGR) in…

Hims & Hers Health Set to Join S&P SmallCap 600

Hims & Hers Health to join S&P SmallCap 600, replacing Vector Group. Learn how this index change impacts the Health…

Hims & Hers Health Set to Join S&P SmallCap 600

Hims & Hers Health, Inc. (NYSE:HIMS) will replace Vector Group Ltd (NYSE:VGR) in the S&P SmallCap 600 effective prior to…

Weight loss initiative empowers frontline heroes

Mihir Gandhi and Dr. Jessica Yu join Lady T to discuss how Hims & Hers provides weight loss treatment to…

Todays Stocks on Sale: HIMS and More

Bearish investors decided to classify Hims & Hers Health (HIMS) as an obesity drug supplier. HIMS stock lost 9.6% on…

Hims & Hers Offers Affordable Weight Loss Solutions for Frontline Heroes

Over 100 million Americans face weight-related challenges, but new GLP-1 medications offer hope. Barriers like high costs and shortages prevent…

Weight Loss Advice

Justin spoke with Mihir Gandhi and Dr. Jessica Yu who are two medical professionals representing Hims & Hers. The focus…

Massive News for Hims & Hers Stock: The Truth About Todays Move @themotleyfool #stocks $HIMS $LLY

Hims & Hers may not be hurt by GLP-1 news the way investors think.…

Massive News for Hims & Hers Stock: The Truth About Todays Move

Hims & Hers may not be hurt by GLP-1 news the way investors think.…

Massive News for Hims & Hers Stock: The Truth About Todays Move

Hims & Hers may not be hurt by GLP-1 news the way investors think.…

Quarry LP Cuts Stock Position in Hims & Hers Health, Inc. (NYSE:HIMS)

Quarry LP decreased its holdings in Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) by 91.8% in the…

Trotz FDA-Entscheidung zu Eli Lilly: Hims & Hers profitiert weiter vom Boom günstiger Wegovy-Alternativen

Die Nachfrage nach günstigeren Alternativen zu den teuren GLP-1-Gewichtsverlustmedikamenten von Eli Lilly und Novo Nordisk explodiert – und Unternehmen wie…

Hims & Hers Health Inc (HIMS-N) Quote

Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.…

Hims & Hers Health stock tanks after FDA says competitor Eli Lillys weight-loss drug shortage is over

The San Francisco telehealth company had capitalized on the shortage by making copycat versions of popular brand-name GLP-1 medications.…

Hims & Hers health CEO sells over $6 million in company stock By Investing.com

Hims & Hers health CEO sells over $6 million in company stock…

Hims & Hers health CFO sells over $219k in company stock By Investing.com

Hims & Hers health CFO sells over $219k in company stock…

Check Out What Whales Are Doing With HIMS - Hims & Hers Health (NYSE:HIMS)

…

Is Hims & Hers rally at risk as GLP-1 shortages ease?

Hims & Hers (NYSE:HIMS), the telehealth platform that offers compounded versions of weight loss drugs, dropped more than 10% on…

Is Hims & Hers rally at risk as GLP-1 shortages ease?

Hims & Hers (NYSE:HIMS), the telehealth platform that offers compounded versions of weight loss drugs, dropped more than 10% on…